Medical and Pharmaceutical Enliven Therapeutics stock climbs on upgrades, sector validation from Merck acquisition Enliven Therapeutics is a clinical-stage biotech company focused on developing targeted cancer drugs Joseph Morton5 days ago
Medical and Pharmaceutical 60 Degrees Pharma flies after curing tick disease in small-scale study The company is planning an NDA submission for its flagship drug as a Babesiosis treatment Rowan DunneMarch 12, 2026
Medical and Pharmaceutical Galleri shows promise in large U.S. based clinical trial Researchers believe this approach could allow doctors to catch cancers much earlier Joseph MortonOctober 20, 2025
Medical and Pharmaceutical Regulus Therapeutics shares jump 135% on news of acquisition by Novartis The buyer is offering a significant premium to acquire Regulus Joseph MortonApril 30, 2025
Medical and Pharmaceutical Corcept Therapeutics shares double on solid Phase 3 results for ovarian cancer treatment Relacorilant is designed to address disorders linked to the stress hormone cortisol Joseph MortonMarch 31, 2025
Medical and Pharmaceutical Is Cardiff Oncology 15% bump due to positive clinical trials or a short squeeze? Individual biotech stocks often decouple from macro trends when company developments or investor enthusiasm take center stage Joseph MortonMarch 12, 2025
Medical and Pharmaceutical Lipella Pharmaceuticals skyrockets on FDA access approval for mouth disease treatment The stock was up by about 200% during early trading hours Rowan DunneFebruary 6, 2025
Beverages Quantum BioPharma soars on clinical trial success with ‘unbuzzd’ hangover cure supplement Shares are currently up by over 110% on the Nasdaq Rowan DunneFebruary 4, 2025
Health & Wellness Akero Therapeutics nearly doubles stock price on positive clinical studies MASH is a more severe form of metabolic dysfunction-associated steatotic liver disease formerly known as non-alcoholic fatty liver disease Joseph MortonJanuary 27, 2025
Medical and Pharmaceutical Phio Pharmaceuticals skyrockets on skin cancer drug trial success Shareholders are having a pretty stellar Monday with the immense gains Rowan DunneJanuary 13, 2025